Alterity Therapeutics Statistics
Total Valuation
ASX:ATH has a market cap or net worth of AUD 100.40 million. The enterprise value is 95.97 million.
Market Cap | 100.40M |
Enterprise Value | 95.97M |
Important Dates
The next estimated earnings date is Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:ATH has 9.13 billion shares outstanding. The number of shares has increased by 104.33% in one year.
Current Share Class | 9.13B |
Shares Outstanding | 9.13B |
Shares Change (YoY) | +104.33% |
Shares Change (QoQ) | +10.82% |
Owned by Insiders (%) | 3.29% |
Owned by Institutions (%) | 35.48% |
Float | 7.39B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 26.96 |
PB Ratio | 12.90 |
P/TBV Ratio | 12.90 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.85 |
EV / Sales | 25.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.84 |
Quick Ratio | 3.76 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -155.77% and return on invested capital (ROIC) is -99.57%.
Return on Equity (ROE) | -155.77% |
Return on Assets (ROA) | -78.37% |
Return on Invested Capital (ROIC) | -99.57% |
Return on Capital Employed (ROCE) | -262.19% |
Revenue Per Employee | 372,449 |
Profits Per Employee | -1.98M |
Employee Count | 10 |
Asset Turnover | 0.23 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:ATH has paid 46,088 in taxes.
Income Tax | 46,088 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +120.00% in the last 52 weeks. The beta is 0.72, so ASX:ATH's price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | +120.00% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 52.24 |
Average Volume (20 Days) | 10,417,820 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ATH had revenue of AUD 3.72 million and -19.79 million in losses. Loss per share was -0.00.
Revenue | 3.72M |
Gross Profit | 3.54M |
Operating Income | -20.53M |
Pretax Income | -19.74M |
Net Income | -19.79M |
EBITDA | -20.49M |
EBIT | -20.53M |
Loss Per Share | -0.00 |
Balance Sheet
The company has 4.54 million in cash and 105,831 in debt, giving a net cash position of 4.43 million or 0.00 per share.
Cash & Cash Equivalents | 4.54M |
Total Debt | 105,831 |
Net Cash | 4.43M |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 7.79M |
Book Value Per Share | 0.00 |
Working Capital | 7.71M |
Cash Flow
Operating Cash Flow | -16.47M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 95.14% |
Operating Margin | -551.15% |
Pretax Margin | -530.10% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ASX:ATH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -104.33% |
Shareholder Yield | n/a |
Earnings Yield | -19.71% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ASX:ATH has an Altman Z-Score of -29.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -29.73 |
Piotroski F-Score | 3 |